Portfolio (Quarterly)
Guide ↗
Spruce Street Capital LP
· CIK 0002050194| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | INHIBIKASE THERAPEUTICS INC | — | 3,581,603.0 | $7.3M | 1.43% | NEW | — | $2.03 | — |
| 22 | — | RESEARCH ALLIANCE CORP III | — | 500,000.0 | $5.3M | 1.05% | NEW | — | $10.70 | — |
| 23 | HLXC | HELIX ACQUISITION CORP III | Financial Services | 500,000.0 | $5.3M | 1.04% | NEW | — | $10.64 | -1.1% |
| 24 | ZLAB | ZAI LAB LTD | Healthcare | 279,110.0 | $5.3M | 1.04% | NEW | — | $19.00 | +34.2% |
| 25 | — | ACHIEVE LIFE SCIENCE INC | — | 736,637.0 | $4.8M | 0.94% | NEW | — | $6.53 | — |
| 26 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 928,593.0 | $4.3M | 0.85% | NEW | — | $4.66 | -22.2% |
| 27 | ALEC | ALECTOR INC | Healthcare | 2,101,068.0 | $4.2M | 0.83% | NEW | — | $2.01 | -7.5% |
| 28 | LONA | LEONABIO INC | Healthcare | 393,701.0 | $3.6M | 0.71% | NEW | — | $9.19 | -52.3% |
| 29 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 231,585.0 | $3.5M | 0.68% | NEW | — | $14.94 | -26.8% |
| 30 | — | JATT II ACQUISITION CORP | — | 160,000.0 | $1.8M | 0.36% | NEW | — | $11.36 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.7%
Financial Services
1.3%